Table 2.
Demographic and surgical characteristics of patients randomized to intraperitoneal chemotherapy.
| N | ||
|---|---|---|
| Age | 428 | 57 years (IQR 49–65 years) |
| Race | 428 | |
| White | 91.1% (390) | |
| Other | 8.9% (38) | |
| GOG performance status | 428 | |
| 0 | 70.6% (302) | |
| 1 | 24.1% (103) | |
| 2 | 5.4% (23) | |
| Tumor grade | 428 | |
| 1 | 11.4% (49) | |
| 2 | 38.3% (164) | |
| 3 | 50.2% (215) | |
| Histology | 428 | |
| Not CC/mucinous | 93.7% (401) | |
| CC/mucinous | 6.3% (27) | |
| Recurrence | 428 | |
| Yes | 73.1% (313) | |
| No | 26.9% (115) | |
| Surgical stage | 405 | |
| IIIA | 5.7% (23) | |
| IIIB | 11.4% (46) | |
| IIIC | 83.0% (336) | |
| Bowel resection | 388 | |
| Yes | 28.6% (111) | |
| No | 71.4% (277) | |
| Tumor size before debulking | 229 | |
| Microscopic | 0.4% (1) | |
| ≤0.5 cm | 1.3% (3) | |
| 0.6–1.0 cm | 1.7% (4) | |
| 1.1–2.0 cm | 0.4% (1) | |
| 2.1–5.0 cm | 4.8% (11) | |
| >5.0 cm | 91.3% (209) | |
| Residual disease | 352 | |
| Microscopic | 35.5% (125) | |
| ≤0.5 cm | 48.9% (172) | |
| 0.6–1.0 cm | 15.3% (54) | |
| 1.1–2.0 cm | 0.3% (1) | |
| Pelvic lymph node dissection | 419 | |
| No | 48.4% (203) | |
| Yes | 51.6% (216) | |
| Paraaortic lymph node dissection | 416 | |
| No | 52.6% (219) | |
| Yes | 47.4% (197) | |
| Nodal metastasis | 428 | |
| Negative | 28.3% (121) | |
| Positive | 31.1% (133) | |
| Unknown | 40.7% (174) |
N is the number of non-missing values. Numbers after percents are frequencies.